Synthesis of complex intermediates for the study of a dehydratase from borrelidin biosynthesis

  1. ‡,1,2 ,
  2. ‡,1 ,
  3. 1 and
  4. 2
1Institut für Organische Chemie und Biomolekulares Wirkstoffzentrum, Leibniz Universität Hannover, Schneiderberg 1B, 30167 Hannover, Germany
2Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, United Kingdom
  1. Corresponding author email
  2. ‡ Equal contributors
Guest Editor: J. S. Dickschat
Beilstein J. Org. Chem. 2014, 10, 634–640. https://doi.org/10.3762/bjoc.10.55
Received 30 Aug 2013, Accepted 30 Jan 2014, Published 11 Mar 2014
Full Research Paper
cc by logo

Abstract

Herein, we describe the syntheses of a complex biosynthesis-intermediate analogue of the potent antitumor polyketide borrelidin and of reference molecules to determine the stereoselectivity of the dehydratase of borrelidin polyketide synthase module 3. The target molecules were obtained from a common precursor aldehyde in the form of N-acetylcysteamine (SNAc) thioesters and methyl esters in 13 to 15 steps. Key steps for the assembly of the polyketide backbone of the dehydratase substrate analogue were a Yamamoto asymmetric carbocyclisation and a Sakurai allylation as well as an anti-selective aldol reaction. Reference compounds representing the E- and Z-configured double bond isomers as potential products of the dehydratase reaction were obtained from a common precursor aldehyde by Wittig olefination and Still–Gennari olefination. The final deprotection of TBS ethers and methyl esters was performed under mildly acidic conditions followed by pig liver esterase-mediated chemoselective hydrolysis. These conditions are compatible with the presence of a coenzyme A or a SNAc thioester, suggesting that they are generally applicable to the synthesis of complex polyketide-derived thioesters suited for biosynthesis studies.

Introduction

Borrelidin (1) is a macrolactone polyketide natural product with promising antibacterial, antimalarial, anticancer and anti-angiogenesis activities, which are probably caused by the inhibition of threonyl-tRNA synthetase and apoptosis induction by caspase activation [1-4]. It bears several unusual structural elements like a cyclopentane ring and a carbonitrile (Figure 1a), which are built-up by unconventional biosynthesis mechanisms [5,6]. The carbonitrile for example is probably formed by allylic oxidation of the 12-methyl group in 12-desnitrile-12-methylborrelidin to the corresponding aldehyde and transamination to the amine followed by oxidation [6]. In the course of our studies on borrelidin biosynthesis, we became interested in the formation of the (12Z,14E)-diene [7]. Z-configured double bonds are much rarer in polyketides than their E-configured counterparts, and their biosynthesis has not been thoroughly investigated yet [7-9].

[1860-5397-10-55-1]

Figure 1: a) Structure of borrelidin (1); b) PKS intermediates are attached to an acyl carrier protein domain (ACP) via a 4'-phosphopantetheine linker, giving acyl-ACPs (2); c) BorDH3 catalyzes the dehydration of ACP-bound 3-hydroxyacylate 3 to one of the ACP-bound enoates 4a or 4b. The configuration of the double bond in the dehydration product is presently unknown. In a previous study, we have shown that BorDH3 only accepts surrogates with the shown 2D,3D-configuration if incubated with simple 3-hydroxy-2-methyl-SNAc pentanoates [7,12].

Gene cluster analysis suggested that the double bond at position 12 in 1 is installed by the dehydratase of polyketide synthase (PKS) module 3 (BorDH3). Characteristic residues in the active site of the preceding ketoreductase point towards a 3D configuration of the BorDH3 precursor 3 [10,11]. Furthermore, we have shown in a previous study that BorDH3 preferentially accepts the 2D,3D-configured precursor, if all four potential stereoisomers of 3-hydroxy-2-methyl-SNAc-pentanoate model substrates are presented [7].

A commonly accepted model suggests that DHs from PKS I systems catalyze the removal of water by syn-dehydration and that a 2D,3D-configured precursor should lead to an E-configured BorDH3 product [10]. However, in the case of borrelidin this is in contradiction to the structure of the natural product in which a Z-configured double bond is present at position 12. In the borrelidin gene cluster, there is no obvious gene coding for an isomerase, which might be able to catalyze the inversion of a double bond configuration. Consequently, the Z-configured double bond must be installed either directly by BorDH3 or by E/Z-isomerisation of an initially formed E-configured double bond via a not yet elucidated mechanism in downstream biosynthetic processes.

Our aim was to assay the stereochemical course of the dehydratase of polyketide synthase (PKS) module 3 (BorDH3) in vitro. Therefore, the surrogate 5a for BorDH3 as well as reference molecules such as 6a and 6b and the corresponding methyl esters 7a and 7b, which resemble the potential assay products or easily accessible derivatives of it, are required (Figure 1c, Scheme 1).

[1860-5397-10-55-i1]

Scheme 1: Retrosynthetic analysis of surrogate substrates for BorDH3 and reference molecules for enzyme assays (5a, 6a, 6b, 7a and 7b); TBS = tert-butyldimethylsilyl, PMB = p-methoxybenzyl, LG = leaving group.

During chain elongation and reductive processing by PKSs, their intermediates are bound to acetyl carrier proteins (ACPs) via a 4'-phosphopantetheine arm (Figure 1b). It has been shown for other PKS domains that the recognition of this prosthetic group is essential for proper substrate orientation in the active site and catalysis with natural stereoselectivity [13]. To mimic the ACP-bound state of PKS intermediates, their analogues, free SNAc thioesters, are used in enzyme assays.

Alternatively, ACP-bound substrates can be conveniently obtained by loading coenzyme A (CoA) thioesters onto active site serine residues of recombinant ACPs by using 4'-phosphopantetheinyl transferases [12,14]. However, coenzyme A thioesters are synthetically hard to access, especially if the substrate structure is complex.

Results and Discussion

Retrosynthetic analysis of target molecules

One common feature of activated biosynthesis intermediate analogues such as 5a is their relative low stability. In the natural context, PKS intermediates are quickly processed by downstream domains or tailoring enzymes. However, if analogues are synthesized chemically and isolated, it has to be taken into account that they often tend to undergo destructive side reactions. Therefore, mild reaction conditions are required, and the synthetic routes to them should preferably be organized in a divergent fashion that allows flexible access to all target compounds from a stable late-stage synthetic intermediate. For the synthesis of the target compounds presented in this study, a strategy via the common precursor aldehyde 11 was envisaged (Scheme 1).

The situation is additionally complicated by the fact that the polyketide part contains a cyclopentyl carboxylate, which necessitates differentiation of the carboxyl groups at the termini to permit regioselective thioester formation. We decided to avoid late redox transformations. Instead, we achieved differentiation by choice of a chemoselective protection group strategy with removal conditions that are compatible for SNAc thioesters (Scheme 1).

We envisaged the usage of TBS ether for the protection of the secondary hydroxy group and to protect the carboxylic acid as its methyl ester in the precursors 8, 9a, 9b, 10a and 10b. These groups should be cleavable under mildly acidic or esterase-catalyzed conditions. As the presence of a methyl ester would prevent the selective introduction of one thioester into 5a by saponification–thioesterification, we planned transesterification from a suitably activated carboxylic acid derivative 8. Alternatively, direct introduction into 11 with appropriate SNAc thioester building blocks was planned for the synthesis of 6a and 6b.

Starting from aldehyde 11, a common precursor for all molecules required in this study, aldol reaction and following transesterification should lead to thioester 8. The bismethyl esters 7a and 7b as well as the SNAc thioesters 6a and 6b should be accessible from aldehyde 11 through a Horner–Wadsworth–Emmons reaction and the Still–Gennari olefination as well as by a Wittig olefination with stabilised phosphoranes, respectively. The aldehyde 11 should be accessible from the known molecule 13 via 12 [15].

Synthesis of the common precursor aldehyde 11

The synthesis of the common precursor aldehyde 11 was accomplished from di(menth-1-yl)succinate (14) through a known route described by Omura et al. (Scheme 2) [15-17]. The final oxidation state at C10 in 12 was installed after protective group removal to primary alcohol 15 followed by Dess–Martin oxidation, Pinnick oxidation and methylation. Methyl ester 12 was obtained in 10 steps with a good overall yield of 20%. Olefin cross metathesis of alkene 12 with crotonaldehyde in the presence of a second generation Grubbs catalyst required only a short filter column to isolate α,β-unsaturated aldehyde 11 in a pure form.

[1860-5397-10-55-i2]

Scheme 2: Synthesis of the common precursor aldehyde 11. Compound 13 was prepared in six steps and with an overall yield of 40% via a known route by Omura et al. [15]. a) DDQ, CH2Cl2, rt, 30 min (85%); b) DMP, CH2Cl2, rt, 2 h; c) NaOCl, 2-methyl-2-butene, t-BuOH, phosphate buffer, rt, 16 h; d) TMS-CHN2, toluene/MeOH 2:3, rt, 40 min (58% over three steps); e) second generation Grubbs catalyst, crotonaldehyde, CH2Cl2, 40 °C, 120 min (88%); DDQ = 2,3-dichloro-5,6-dicyano-1,4-benzoquinone, Men = (l)-menthyl, DMP = Dess–Martin periodinane, TMS = trimethylsilyl.

Synthesis of DH substrate surrogate

For the synthesis of the DH substrate surrogate 5a we aimed at an anti-selective aldol reaction, which permits efficient access to the desired 2D,3D-stereoisomer followed by a smooth transformation into the SNAc thioester in the presence of a methyl ester function. Amongst others, we tested Paterson’s lactate-derived benzoyl auxiliary, Evans’ magnesium-catalyzed direct aldol reaction, and an Abiko–Masamune-like aldol reaction by using a thiodesoxy variant of the norephedrine-derived auxiliary on simplified model aldehydes as well as on aldehyde 11 [18-21]. However, in all these cases either the aldol reaction itself proved to be low yielding (<20%) or removal conditions of chiral auxiliaries were destructive to the molecule.

The best results were obtained for an anti-selective variant, in which aldehyde 11 was reacted with an (E)-boron enolate formed by the reaction of thiophenol propionate with chlorodicyclohexylborane and dimethylethylamine, similar to the conditions described by Paterson et al. for lactate-derived auxiliaries [18]. In this way, the aldol product was conveniently obtained as an inseparable 1:1 mixture of both 2,3-anti diastereomers 17a and 17b in 57% yield over two steps [22]. Such thiophenol esters readily undergo thiol-exchange reactions and are therefore suitable precursors for SNAc, pantetheine and CoA thioesters [14]. Accordingly, when we treated the mixture of thiophenol esters 17a and 17b with HSNAc and triethylamine in DMF, they underwent clean transesterification furnishing SNAc thioesters 18a and 18b in 70% combined yield [20] (Scheme 3).

[1860-5397-10-55-i3]

Scheme 3: Synthesis of the BorDH3 substrates. a) Thiophenolpropionate, Cy2BCl, Me2EtN, Et2O, −78 °C to −20 °C, 16 h (57% over two steps from 12); b) HSNAc, Et3N, DMF, rt, 16 h (70%); c) THF/HCOOH/H2O (6:3:1), rt, 2 d; d) pig liver esterase, phosphate buffer, rt, 5 d (81% over two steps); e) NaOCl, 2-methyl-2-butene, t-BuOH, phosphate buffer (pH 7.0), rt, 16 h; f) N-hydroxysuccinimide, N,N’-dicyclohexylcarbodiimide, THF, rt, 16 h (50% over three steps from 12); g) HSCoA·3Li, THF/H2O (2:1) adjusted to pH 8.0 by phosphate buffer, 35 °C, 18 h; DMF = N,N-dimethylformamide.

With the mixture of 18a and 18b in hand, we turned to the mild removal of the protection groups. For TBS cleavage, we focused on conditions previously described by us for the removal of an acid-sensitive dioxolane protection group from a CoA thioester [23]. We evaluated the exposure of the model CoA ester 20, synthesized from 11 by Pinnick oxidation and CoA thioesterification via an intermediate activation as N-hydroxysuccinimide ester, to several acids in H2O/THF mixed solvent systems. In 20 the acyl part is similarly functionalized as in the protected SNAc thioesters 18a and 18b. However, the CoA thioester can be regarded as more demanding in terms of sensitivity.

The progress of the reaction was followed by mass spectrometry. While the use of strong acids like p-toluenesulfonic acid or hydrochloric acid led to the decomposition of 20, weaker acids like acetic acid did not lead to any detectable product formation, even after reaction times of up to 20 h. Gratifyingly, treatment with a mixture of THF/HCOOH/H2O (6:3:1), gave a slow conversion into the desired product 21 (see Figure S1 and Figure S2 in Supporting Information File 1). Complete deprotection was achieved after 2 days.

The mixture of SNAc esters 18a and 18b was exposed to the established acidic deprotection conditions and the progress of the reaction was monitored by mass spectrometry. After two days, complete TBS removal was obtained. The crude product was subjected to selective methyl ester cleavage by using pig liver esterase (PLE) [24]. The target molecule was obtained as a mixture of both anti-diastereomers 5a and 5b after 15 steps in 7% overall yield.

Synthesis of reference compounds

We exploited a Wittig reaction with a suitable stabilized phosphorane for the synthesis of (E,E)-diene 6a (Scheme 4). The Wittig compound 24 was obtained in two steps from 2-bromopropionic acid following synthetic procedures described for its acetic acid analogue and the respective methyl ester ylide 26 [25,26]. The reaction of phosphorane 24 with 11 under neutral conditions at 50 °C gave the desired diene 9a in very good 88% yield and in nearly perfect E-selectivity. The protection groups were removed from 9a under the previously established conditions to finally give target SNAc thioester 6a in a total yield of 12% over 14 steps. Alternative attempts to synthesize 9a and 9b by Horner–Wadsworth–Emmons olefination and Still–Gennari olefination with the respective phosphonates gave no reaction product at all (Horner–Wadsworth–Emmons olefination) or only the (E,E)-diene 10a instead of the desired E,Z-configured product 10b (Still–Gennari olefination).

[1860-5397-10-55-i4]

Scheme 4: Synthesis of reference compounds for the BorDH3 assay. a) 24, CH2Cl2, 50 °C, 3 h (88% over two steps); b) THF/HCOOH/H2O (6:3:1), rt, 2 d (62% for 7a, 57% for 7b); c) pig liver esterase, phosphate buffer, rt, 3 d (67% over two steps from 9a); d) 25, NaH, THF, 0 °C, 3 h (18% over two steps from 12) or 26, CH2Cl2, 50 °C, 21 h (64% over two steps from 12); e) 27, 18-crown-6, K2CO3, THF, −20 °C then 0 °C for 5 h (47% over two steps from 12); f) HSNAc, EDC, DMAP, CH2Cl2, rt, 16 h (78%); g) PPh3, H2O, 70 °C, 11 h, then NaOH, rt (64%).

In order to obtain alternative reference compounds for both potential products of the BorDH3 enzyme assay, we synthesized double bond isomers 7a and 7b. To be able to compare them to the products in the crude BorDH3 assay mixture, the latter will be transformed into their corresponding methyl esters by saponification and following methylation with trimethylsilyldiazomethane.

The fully protected E-isomer 10a was obtained in 18% yield by a Horner–Wadsworth–Emmons reaction with phosphonate 25 or, alternatively, in 64% yield by a Wittig reaction with stabilized phosphorane 26. The Z-isomer 10b was synthesized by Still–Gennari olefination using phosphonate 27 in 47% yield. The yield for the deprotection step was satisfying (61% for 7a and 57% for 7b) in both cases, indicating that both isomers are configurationally stable under these conditions. The overall yield over 13 steps was 8% for 7a and 5% for 7b.

(E,E)-diene 6a will find application in the comparative NMR evaluation of a large scale BorDH3 enzyme assay of substrates 5a and 5b. Together with the successful synthesis of 5a and 5b and the availability of the isomers 7a and 7b, this sets the stage to determine the stereoselectivity of BorDH3.

Conclusion

We reported on the synthesis of a complex substrate and appropriate reference compounds for assaying the activity of the dehydratase in module 3 of the borrelidin polyketide synthase. All the target molecules 5a, 6a, 7a and 7b were obtained in 13 to 15 step sequences with overall yields of up to 12%. The routes diverged from a common precursor aldehyde 11, which had been prepared in 18% yield over 11 steps, and had exploited the Yamamoto asymmetric carbocyclization and MgBr2-mediated Sakurai reaction to set up the three stereogenic centres.

The construction of the backbone was accomplished by anti-selective aldol reaction or olefination by using the respective phosphonates or phosphoranes. A notable achievement was the development of a chemoselective, mild protection strategy, which is based on an acidic treatment to cleave a silyl ether and a highly efficient and less common late stage ester hydrolysis by using pig liver esterase. Preliminary tests suggest the compatibility of these conditions with coenzyme A thioesters, indicating that the chosen strategy has broad potential in the future synthesis of similarly (or even more) complex polyketide-derived coenzyme A thioesters.

Thus, the presented strategy enables for the first time the in vitro assaying of a potential Z-selective dehydratase domain from a polyketide synthase with suitable precursor molecules. These experiments are currently ongoing in our lab.

Supporting Information

The supporting information provides reaction details, analytical data, and copies of 1H and 13C NMR spectra.

Supporting Information File 1: Procedures.
Format: PDF Size: 912.5 KB Download
Supporting Information File 2: NMR spectra.
Format: PDF Size: 3.0 MB Download

Acknowledgements

We thank the Marie Curie program of the European Union and the Emmy Noether program of the DFG for funding. We would also like to thank the NMR facility and the mass facility of the OCI Hanover as well as Prof. Andreas Kirschning and his group for general support and helpful discussion.

References

  1. Berger, J.; Jampolsky, L. M.; Goldberg, M. Arch. Biochem. 1949, 22, 476–478.
    Return to citation in text: [1]
  2. Keller-Schierlein, W. Helv. Chim. Acta 1967, 50, 731–753. doi:10.1002/hlca.19670500303
    Return to citation in text: [1]
  3. Otoguro, K.; Ui, H.; Ishiyama, A.; Kobayashi, M.; Togashi, H.; Takahashi, Y.; Masuma, R.; Tanaka, H.; Tomoda, H.; Yamada, H.; Omura, S. J. Antibiot. 2003, 56, 727–729. doi:10.7164/antibiotics.56.727
    Return to citation in text: [1]
  4. Kawamura, T.; Liu, D.; Towle, M. J.; Kageyama, R.; Tsukahara, N.; Wakabayashi, T.; Littlefield, B. A. J. Antibiot. 2003, 56, 709–715. doi:10.7164/antibiotics.56.709
    Return to citation in text: [1]
  5. Olano, C.; Wilkinson, B.; Sánchez, C.; Moss, S. J.; Sheridan, R.; Math, V.; Weston, A. J.; Braña, A. F.; Martin, C. J.; Oliynyk, M.; Méndez, C.; Leadlay, P. F.; Salas, J. A. Chem. Biol. 2004, 11, 87–97. doi:10.1016/j.chembiol.2003.12.018
    Return to citation in text: [1]
  6. Olano, C.; Moss, S. J.; Braña, A. F.; Sheridan, R. M.; Math, V.; Weston, A. J.; Méndez, C.; Leadlay, P. F.; Wilkinson, B.; Salas, J. A. Mol. Microbiol. 2004, 52, 1745–1756. doi:10.1111/j.1365-2958.2004.04090.x
    Return to citation in text: [1] [2]
  7. Vergnolle, O.; Hahn, F.; Baerga-Ortiz, A.; Leadlay, P. F.; Andexer, J. N. ChemBioChem 2011, 12, 1011–1014. doi:10.1002/cbic.201100011
    Return to citation in text: [1] [2] [3] [4]
  8. Valenzano, C. R.; You, Y.-O.; Garg, A.; Keatinge-Clay, A.; Khosla, C.; Cane, D. E. J. Am. Chem. Soc. 2010, 132, 14697–14699. doi:10.1021/ja107344h
    Return to citation in text: [1]
  9. Guo, X.; Liu, T.; Valenzano, C. R.; Deng, Z.; Cane, D. E. J. Am. Chem. Soc. 2010, 132, 14694–14696. doi:10.1021/ja1073432
    Return to citation in text: [1]
  10. Reid, R.; Piagentini, M.; Rodriguez, E.; Ashley, G.; Viswanathan, N.; Carney, J.; Santi, D. V.; Hutchinson, C. R.; McDaniel, R. Biochemistry 2003, 42, 72–79. doi:10.1021/bi0268706
    Return to citation in text: [1] [2]
  11. Caffrey, P. ChemBioChem 2003, 4, 654–657. doi:10.1002/cbic.200300581
    Return to citation in text: [1]
  12. Carreras, C. W.; Gehring, A. M.; Walsh, C. T.; Khosla, C. Biochemistry 1997, 36, 11757–11761. doi:10.1021/bi971350+
    Return to citation in text: [1] [2]
  13. Bali, S.; Weissman, K. S. ChemBioChem 2006, 7, 1935–1942. doi:10.1002/cbic.200600285
    Return to citation in text: [1]
  14. Mishra, P. K.; Drueckhammer, D. G. Chem. Rev. 2000, 100, 3283–3310. doi:10.1021/cr990010m
    Return to citation in text: [1] [2]
  15. Nagamitsu, T.; Takano, D.; Fukuda, T.; Otoguro, K.; Kuwajima, I.; Harigaya, Y.; Omura, S. Org. Lett. 2004, 6, 1865–1867. doi:10.1021/ol049356w
    Return to citation in text: [1] [2] [3]
  16. Misumi, A.; Iwanaga, K.; Furuta, K.; Yamamoto, H. J. Am. Chem. Soc. 1985, 107, 3343–3345. doi:10.1021/ja00297a048
    Return to citation in text: [1]
  17. Compound 14 was prepared in quantitative yield by refluxing succinic acid and (l)-menthol for 4 h in toluene at 120 °C under Dean–Stark conditions.
    Return to citation in text: [1]
  18. Paterson, I.; Wallace, D. J.; Cowden, C. J. Synthesis 1998, 639–652. doi:10.1055/s-1998-5929
    Return to citation in text: [1] [2]
  19. Evans, D. A.; Tedrow, J. S.; Shaw, J. T.; Downey, C. W. J. Am. Chem. Soc. 2002, 124, 392–393. doi:10.1021/ja0119548
    Return to citation in text: [1]
  20. Fanjul, S.; Hulme, A. N.; White, J. W. Org. Lett. 2006, 8, 4219–4222. doi:10.1021/ol0614774
    Return to citation in text: [1] [2]
  21. Heathcock, C. H.; Pirrung, M. C.; Montgomery, S. H.; Lampe, J. Tetrahedron 1981, 37, 4087–4095. doi:10.1016/S0040-4020(01)93284-3
    Return to citation in text: [1]
  22. The relative stereochemistry was determined from the characteristic 3J coupling constant of 7.5 Hz between the protons at positions 2 (dq at 2.87 ppm) and 3 (dd at 4.26 ppm) in the 1H NMR spectrum. HPLC–MS analysis of the mixture of 17a and 17b suggested an approximate 1:1 mixture of both diastereomers.
    Return to citation in text: [1]
  23. Sun, Y.; Hahn, F.; Demydchuk, Y.; Chettle, J.; Tosin, M.; Osada, H.; Leadlay, P. F. Nat. Chem. Biol. 2010, 6, 99–101. doi:10.1038/nchembio.285
    Return to citation in text: [1]
  24. Morimoto, Y.; Terao, Y.; Achiwa, K. Chem. Pharm. Bull. 1987, 35, 2266–2271. doi:10.1248/cpb.35.2266
    Return to citation in text: [1]
  25. Gilbert, I. H.; Ginty, M.; O’Neill, J. A.; Simpson, T. J.; Staunton, J.; Willis, C. L. Bioorg. Med. Chem. Lett. 1995, 5, 1587–1590. doi:10.1016/0960-894X(95)00276-Y
    Return to citation in text: [1]
  26. Handa, M.; Scheidt, K. A.; Bossart, M.; Zheng, N.; Roush, W. A. J. Org. Chem. 2008, 73, 1031–1035. doi:10.1021/jo702250z
    Return to citation in text: [1]
Other Beilstein-Institut Open Science Activities